Utilizing proprietary technology developed by Professor Su-Chun Zhang at the University of Wisconsin-Madison, we direct human stem cells, including iPSCs (licensed from iPS Japan) to subtype-specific neuronal progenitors, which are expanded to large quantities, followed by rapid maturation.

This unique combination of technology enables large-scale production of highly enriched, functionally specialized neural cells with consistent quality for drug discovery and cell therapy.